Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

For Older Women With Diabetes, Two Dietary Oils, Two Sets Of Benefits
A study comparing how two common dietary oil supplements affect body composition suggests that both oils, by themselves, can lower body fat in obese postmenopausal women with Type 2 diabetes.
generic viagra online
Educate Deferred Donors On World Blood Donor Day, June 14th
In recognition of World Blood Donor Day on June 14th, the National Anemia Action Council (NAAC) is providing the online tutorial Anemia & Blood Donation to blood donors who have been deferred because of a low blood count.
News of the day
HIV/AIDS Advocates React To Obama's Proposed Global Health Initiative
Some HIV/AIDS advocates have voiced disappointment with the level of HIV/AIDS funding in President Obama"s proposed $63 billion, six-year global health initiative, VOA News reports. According to VOA News, the advocates say that Obama has not met pledges he made as a presidential candidate, while other say that the "picture is more complicated." According to the Global AIDS Alliance, Obama previously pledged to dedicate $50 billion over five years to HIV/AIDS, TB and malaria, but has instead proposed $51 billion over six years. GAA Executive Director Paul Zeitz said this proposal translates into significantly less annual funding for PEPFAR (Kilner, VOA News, 5/19). Zeitz said, "President Obama has a moral obligation to demonstrate global leadership on behalf of the poorest and most marginalized people of the world, especially in Africa," adding, "But by turning his back on those needs, the president is betraying the trust of tens of millions of people" (Pflanz, Daily Telegraph, 5/18). Advocates estimate that the funding shortfall could result in about one million people going without HIV/AIDS treatment and about 2.9 million women going without treatment to prevent mother-to-child HIV transmission. James Kamau, coordinator for the Kenya Treatment Action Movement, said that one effect of Obama"s proposal is that other donor countries could take similar actions, leading to additional cuts. "In Kenya here we say when the lead sheep limps then it does not get the others to the pastures," Kamau said, adding, "Now if [Obama] cuts back funding on the Global Fund, then the rest of the people will follow suit" (VOA News, 5/19). Some have welcomed Obama"s proposal, saying that it has expanded the focus of global health initiatives to include other health issues that can be treated at a low cost but have not received as much attention, VOA News reports. Obama"s proposal includes $12 billion for these additional areas of focus, including more emphasis on maternal health and health infrastructure, according to VOA News.According to VOA News, Obama"s proposal might be more than Congress is willing to allocate during the economic crisis. The current budget resolution under consideration by Congress would allocate $51 billion for foreign aid in FY 2010, almost $3 billion less than what Obama requested (VOA News, 5/18). African Government Spending on Health
Medical Devices

Second U.S. Independent Laboratory Confirms That Oculus Innovative Sciences' Microcyn(R) Technology Effective At Inactivating H1N1 Swine Flu

Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, which includes new formulations intended to reduce the use of antibiotics by preventing or treating infections including those caused by bacteria and viruses, has confirmed the effectiveness of Microcyn® Technology at inactivating the H1NI Swine Influenza A. In a virucidal time-kill suspension test conducted by an independent laboratory, BioScience Laboratories, Inc., the specific Microcyn Technology formulation reduced infectivity of the swine flu virus by 4.00log10 (99.99%) reduction after just 30-seconds exposure. BioScience Laboratories, working in cooperation with the U.S. Department of Agriculture, received formal approval to acquire, house and evaluate the specific swine influenza virus in April 2009. Oculus is preparing the study data for submission to both the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to help accelerate global awareness of Microcyn Technology"s ability to effectively and safely reduce the incidence of transmission of this pandemic virus. However, specific product formulations of the Microcyn Technology have not yet been reviewed or approved by any regulatory body for a specific swine flu indication. "We experienced increased consumer use of our Microcyn-based products in April and May when the swine flu first hit in Mexico," says Sergio Caleti, sales director of Oculus Innovative Sciences of Mexico. "This resulted in an uptick in product sales along with a corresponding increase in market awareness of the Microcyn Technology in Mexico. We are leveraging this increased name recognition with the introduction this year of a family of Mexican consumer products including a new pediatric skin treatment and smaller consumer packaging for the Microcyn-based wound care products." Oculus previously announced a humanitarian program in which Microcyn Technology is provided pro bono to organizations that are responding to worldwide healthcare challenges precipitated by natural disaster or epidemic disease. The product will be available according to the regulatory claims in each area and at the request of emergency responders and foundations. Representatives of these groups are encouraged to contact Oculus" global outreach at go@oculusis.com. About H1N1 Influenza (Swine Influenza) According to the Center for Disease Control and Prevention, novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in April 2009. The virus is infecting people and is spreading from person to person, sparking a growing outbreak of illness in the United States. An increasing number of cases are being reported internationally as well. It"s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread -- mainly through the coughs and sneezes of people who are sick with the virus. On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the novel influenza A (H1N1) virus. A Phase 6 designation indicates that a global pandemic is underway. More than 70 countries are now reporting cases of human infection with novel H1N1 flu. This number has been increasing over the past few weeks, but many of the cases reportedly had links to travel or were localized outbreaks without community spread. The WHO designation of a pandemic alert Phase 6 reflects the fact that there are now ongoing community-level outbreaks in multiple parts of world. Oculus


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009